ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

INHERITED CANCER GENETICS

Cardiff and Vale University Health Board · Contract details notice on Find a Tender

Tender information last checkedLast checked 27 Sept 2026, 04:41.

Opportunity overview

Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.This service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.The selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.Introducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.Awarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Informed Genetics

Match pending…
Contract value
£450k
Awarded
Not supplied
Contract signed
7 Jul 2026
Including VAT
£540k
Award ID
1
Status
active
Identifier
GB-PPON PZXY-1897-VDDJ
Location
Birmingham, UKG31, B32 1AF, United Kingdom

Classification

No classification was supplied.

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
CAV-DIR (26-27) 49
Status
complete
Procurement Method
direct
Procurement Method Details
Direct award
Why this procedure was chosen
Single supplier – technical reasons The requirement relates to a highly specialised clinical service for inherited cancer genetic testing, which requires specific technical capability, accredited laboratory processes, and integration with existing clinical pathways. The identified supplier has the necessary infrastructure, validated methodologies, and established interfaces with the All Wales Medical Genomics Service (AWMGS), enabling continuity of testing, reporting, and data management. These technical requirements cannot be readily replicated by alternative suppliers within the required timeframe without significant disruption. Furthermore, the supplier’s ability to deliver within existing turnaround times, manage current demand, and support backlog recovery is dependent on proprietary systems, validated workflows, and specialist expertise. Transitioning to an alternative supplier would necessitate duplication of validation processes, interface development, and clinical assurance activity, introducing unacceptable operational and clinical risk. Single supplier – unique work of art or performance (proprietary justification) The service provision is considered proprietary in nature due to the supplier’s established integration within the current service model, including embedded processes, reporting mechanisms, and clinical pathways specific to AWMGS requirements. The supplier is already delivering testing services aligned to the Health Board’s specifications, with proven performance in managing complex and high-volume diagnostic workloads. Their service includes unique elements such as established data flows, validated testing protocols, and familiarity with Welsh clinical pathways, which collectively form a bespoke service offering that is not readily transferable. Any change in supplier would require significant revalidation of testing processes, redevelopment of interfaces, and onboarding of clinical pathways, which would disrupt service delivery and delay patient diagnosis. This establishes the supplier as the only provider capable of delivering the required service without interruption, therefore justifying a sole supplier award on the basis of proprietary service delivery.

Legal basis

Id
2023/54
Scheme
UKPGA

Procedure reasons

Entry 1
Id
singleSuppliersIntellectualPropertyExclusiveRights
Entry 2
Id
singleSuppliersTechnicalReasons

Lots and requirements

Entry 1
Id
1
Status
complete

Published documents

Entry 1
Id
conflictOfInterest
Document Type
conflictOfInterest
Description
Not published

Buyer, suppliers and contacts

Organisation 1
Name
Cardiff and Vale University Health Board
Id
GB-PPON-PPPR-7969-BTJG

Identifier

Scheme
GB-PPON
Id
PPPR-7969-BTJG

Address

Street Address
Woodland House
Locality
Cardiff
Postal Code
CF14 4HH
Country
GB
Country Name
United Kingdom
Region
UKL22

Contact

Name
Nicola Williams
Telephone
+442921500649

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthoritySubCentralGovernment
Description
Public authority - sub-central government
Entry 2
Scheme
UK_CA_DEVOLVED_REGULATIONS
Id
GB-WLS
Description
Welsh devolved regulations apply
Organisation 2
Name
NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)
Id
GB-PPON-PXWV-6492-CGMN
Role Details
The NHS Wales Shared Services Partnership (NWSSP) plays a vital role in supporting NHS Wales by delivering a wide range of professional, technical, and administrative services. It is hosted by Velindre University NHS Trust, which means Velindre provides the governance and infrastructure to support NWSSP’s operations, but NWSSP itself serves all NHS organisations across Wales.

Identifier

Scheme
GB-PPON
Id
PXWV-6492-CGMN

Address

Street Address
4-5 Charnwood Court Heol Billingsley
Locality
Cardiff
Postal Code
CF15 7QZ
Country
GB
Country Name
United Kingdom
Region
UKL15

Contact

Roles

procuringEntity
Organisation 3
Name
Informed Genetics
Id
GB-PPON-PZXY-1897-VDDJ

Identifier

Scheme
GB-PPON
Id
PZXY-1897-VDDJ

Address

Street Address
Unit 5, quinton business park,11 Ridgeway
Locality
Birmingham
Postal Code
B32 1AF
Country
GB
Country Name
United Kingdom
Region
UKG31

Contact

Roles

supplier

Details

Scale
large
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No

Award information

Award 1
Id
1
Status
active
Main Procurement Category
services

Items

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
85148000
Description
Medical analysis services

Delivery locations

Entry 1
Region
UKL22
Country
GB
Country Name
United Kingdom

Suppliers

Supplier 1
Id
GB-PPON-PZXY-1897-VDDJ
Name
Informed Genetics

Related lots

1

Contracts and changes

Entry 1
Id
1
Award ID
1
Title
INHERITED CANCER GENETICS
Status
active
Above Threshold
Yes
Date Signed
8 Jul 2026, 00:00

Period

Starts
1 Jan 2027, 00:00
Ends
31 Dec 2027, 23:59

Value

Including VAT
540,000
Amount
450,000
Currency
GBP

Documents

Entry 1
Id
A-18951
Document Type
contractSigned
Format
application/pdf
Entry 2
Id
064441-2026
Document Type
contractNotice
Notice Type
UK7
Description
Contract details notice on Find a Tender
Published
9 Jul 2026, 08:23
Format
text/html

Recorded locations

  • Buyer location · Cardiff · UKL22 · CF14 4HH · United Kingdom

Notice and amendment history

3 published notice versions reviewed by ProcuraAxis.

3 VERSIONS
  1. 059783-2026Transparency notice on Find a Tender ·
  2. 059805-2026Contract award notice on Find a Tender ·
  3. 064441-2026Contract details notice on Find a Tender ·